Normal UA Hyperuricemia p
MS(n=239) 15.88 ± 6.89 15.79 ± 6.35 0.914
Men(n=141) 15.89 ± 6.80 15.64 ± 5.44 0.804
<60 year(n=75) 17.88 ± 7.26 15.95 ± 3.99 0.197
≥60 year(n=66) 14.20 ± 5.98 15.19 ± 7.07 0.539
Women(n=98) 15.73 ± 7.00 16.47 ± 8.24 0.634
<60 year(n=42) 19.40 ± 6.03 17.43 ± 6.94 0.356
≥60 year(n=56) 12.05 ± 5.95 16.00 ± 8.88 0.059
NMS (n=376) 16.98 ± 7.71 15.91 ± 7.00 0.197
Men(n=190) 14.84 ± 6.49 14.61 ± 5.92 0.818
<60 year(n=92) 15.46 ± 6.45 15.74 ± 5.67 0.835
≥60 year(n=98) 14.35 ± 6.53 13.08 ± 6.01 0.379
Women(n=186) 10.07 ± 8.23 17.40 ± 7.86 0.2
<60 year(n=102) 20.00 ± 8.55 20.92 ± 8.87 0.644
≥60 year(n=84) 17.71 ± 7.61 14.88 ± 5.54 0.074
Controls(n=87) 18.82 ± 7.67 17.20 ± 8.09 0.41
NMS: Hypertensives without Metabolic Syndrome; MS: Hypertensives with Metabolic Syndrome
Table 3: Comparison of EID between subjects with hyperuricemia and those without hyperuricemia in groups.